BelleTorus Corporation
BelleTorus Corporation, known as Belle.ai, is dedicated to enhancing global skin healthcare access through innovative AI technology. Their mission is to assist healthcare professionals in addressing the unmet demands for dermatology by providing tools that analyze over 1,600 skin conditions from smartphone images. Belle.ai's technology supports healthcare providers with objective scoring for immune-mediated skin disorders and is utilized by researchers and pharmaceutical companies worldwide to study and evaluate skin health treatments.
Industries
N/A
Nr. of Employees
small (1-50)
BelleTorus Corporation
245 First Street Riverview II, 18th Floor Cambridge, MA 02142 USA
Products
Skin image similarity platform (reference repository)
A platform that performs geometric analysis of clinical smartphone images to find similar reference images and text across a large indexed repository of skin conditions.
Image-based severity scoring modules
Modular software components that propose objective initial scores for established dermatology indices (PASI, EASI, NAPSI, IGA, acne metrics) using image comparison to reference examples.
Skin image similarity platform (reference repository)
A platform that performs geometric analysis of clinical smartphone images to find similar reference images and text across a large indexed repository of skin conditions.
Image-based severity scoring modules
Modular software components that propose objective initial scores for established dermatology indices (PASI, EASI, NAPSI, IGA, acne metrics) using image comparison to reference examples.
Expertise Areas
- Dermatology image analysis
- Decentralized clinical trials and imaging endpoints
- Clinical severity scoring and objective assessment
- Digital skin biomarkers and real-world evidence
Key Technologies
- Deep learning (convolutional neural networks)
- Transfer learning
- Wavelet-based image analysis
- Structural ensembling methods
News & Updates
Belle.ai was chosen by CMS to showcase its AI technology for dermatology at the inaugural AI Demo Day.
Belle.ai, in collaboration with UHP, received a contract from ARPA-H to enhance pediatric healthcare using AI.
ARPA-H awarded Belle.ai a $3.5 million contract to expand pediatric telehealth services through AI technology.
Belle.ai was chosen by CMS to showcase its AI technology for dermatology at the inaugural AI Demo Day.
Belle.ai, in collaboration with UHP, received a contract from ARPA-H to enhance pediatric healthcare using AI.
ARPA-H awarded Belle.ai a $3.5 million contract to expand pediatric telehealth services through AI technology.